Increasing the etanercept dose in a treat-to-target approach in juvenile idiopathic arthritis: does it help to reach the target? A post-hoc analysis of the BeSt for Kids randomised clinical trial

Abstract Background Etanercept has been studied in doses up to 0.8 mg/kg/week (max 50 mg/week) in juvenile idiopathic arthritis (JIA) patients. In clinical practice higher doses are used off-label, but evidence regarding the relation with outcomes is lacking. We describe the clinical course of JIA-p...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Bastiaan T. van Dijk (Egilea), Sytske Anne Bergstra (Egilea), J. Merlijn van den Berg (Egilea), Dieneke Schonenberg-Meinema (Egilea), Lisette W.A. van Suijlekom-Smit (Egilea), Marion A.J. van Rossum (Egilea), Yvonne Koopman-Keemink (Egilea), Rebecca ten Cate (Egilea), Cornelia F. Allaart (Egilea), Daniëlle M.C. Brinkman (Egilea), Petra C.E. Hissink Muller (Egilea)
Formatua: Liburua
Argitaratua: BMC, 2024-05-01T00:00:00Z.
Gaiak:
Sarrera elektronikoa:Connect to this object online.
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Internet

Connect to this object online.

3rd Floor Main Library

Aleari buruzko argibideak 3rd Floor Main Library
Sailkapena: A1234.567
Alea 1 Eskuragarri